{
    "title": "Biogen to buy Reata for $6.5 bln to bulk up rare disease portfolio",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12348633/Biogen-buy-Reata-6-5-bln-bulk-rare-disease-portfolio.html",
    "date": "2023-07-28",
    "keywords": [
        "drug",
        "biogen",
        "viehbacher",
        "growth",
        "deal",
        "treatment",
        "drugmaker",
        "price",
        "bhanvi",
        "skyclarys",
        "disorder",
        "launch",
        "disease",
        "reata",
        "acquisition",
        "ceo",
        "christopher",
        "november",
        "path",
        "series",
        "aduhelm",
        "company",
        "competition",
        "topselling",
        "damage",
        "system",
        "foundation",
        "place",
        "delivery",
        "world",
        "statement",
        "musclewasting",
        "muscular",
        "atrophy",
        "type",
        "sclerosis",
        "partner",
        "year",
        "therefore",
        "portfolio",
        "immunology",
        "list",
        "friedreichs",
        "ataxia",
        "infrastructure",
        "challenging",
        "analyst",
        "skorney",
        "approval",
        "blockbuster",
        "share",
        "cash",
        "premium",
        "closing",
        "debt",
        "trading",
        "reporting",
        "satija",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}